Related Experiment Video
Updated: May 7, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Impact of Genetic Testing and Sex Differences among Patients with Familial Hypercholesterolemia: The Hokuriku-plus
Hayato Tada1, Hirofumi Okada1, Shohei Yoshida1
1Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences.
Insights
Male sex and genetic testing are associated with achieving low-density lipoprotein (LDL)-cholesterol treatment targets in heterozygous familial hypercholesterolemia (HeFH). Female patients and those without genetic testing were less likely to reach LDL-cholesterol goals.
Area of Science:
- Cardiology
- Genetics
- Public Health
Background:
- Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder characterized by high LDL-cholesterol levels.
- Effective management of HeFH is crucial to reduce cardiovascular risk.
- Treatment target attainment for LDL-cholesterol is a key metric in managing HeFH.
Purpose of the Study:
- To determine the factors associated with achieving LDL-cholesterol treatment targets in patients with HeFH.
- To investigate the influence of sex and genetic testing on LDL-cholesterol goal attainment.
Main Methods:
- A prospective, observational, multicenter cohort study (Hokuriku-plus FH registry) was conducted in Japan.
- Data from 386 patients with HeFH were analyzed using logistic regression.
- Factors associated with LDL-cholesterol treatment target attainment were assessed.
Main Results:
- Male sex (OR = 2.16) and genetic testing (OR = 1.68) were significantly associated with achieving LDL-cholesterol treatment targets.
- Female patients (24.0%) were less likely to attain targets compared to males (38.1%).
- Patients without genetic testing (24.5%) were less likely to attain targets compared to those with testing (37.1%).
Conclusions:
- Sex bias and lack of genetic testing represent significant barriers in managing HeFH patients.
- These factors may contribute to disparities in achieving LDL-cholesterol treatment goals.
- Addressing these barriers is essential for improving clinical outcomes in HeFH.
Aim:
We aimed to clarify the degree and factors associated with low-density lipoprotein (LDL)-cholesterol treatment target attainment among patients with heterozygous familial hypercholesterolemia (HeFH) using the Hokuriku-plus FH registry.
Methods:
The Hokuriku-plus FH registry (UMIN000038210) was a prospective, observational, multicenter cohort study that enrolled consecutive patients with FH who fulfilled the clinical criteria for FH in Japan from 37 participating hospitals, mostly in the Hokuriku region, from April 2020 to March 2024. This registry collects data on clinical parameters, including lipid levels, physical findings, genetic background, and clinical events. In total, 431 patients were enrolled, and the median followup period was 3.1 years. We assessed the degree and factors associated with LDL-cholesterol treatment target attainment among patients with HeFH using the Hokuriku-plus FH registry.
Results:
Among the 431 patients, sufficient data were collected from 386 patients. Logistic regression analysis revealed that male sex (odds ratio [OR] = 2.16, 95% confidence interval [CI]: 1.14-3.18, p<0.001) and genetic testing (OR = 1.68, 95% CI: 1.10-2.26, p<0.001) were significantly associated with LDL-cholesterol treatment target attainment. In fact, female patients were less likely to attain LDL-cholesterol treatment target than male patients (24.0% vs. 38.1%, p<0.001), and patients who did not undergo genetic testing were less likely to attain LDL-cholesterol treatment target than those who underwent genetic testing (24.5% vs. 37.1%, p<0.001).
Conclusion:
Sex bias and masked genetic status are significant barriers to the clinical management of patients with HeFH.
More Related Videos
Related Concept Videos
Pedigree Analysis
Sex-linked Disorders
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
The Ratio of X Chromosome to Autosomes
Normal male Drosophila has a ratio of one X chromosome to two sets of autosomes. In contrast, normal female...
X-linked Traits
Cholesterol: Significance and Regulation
Considering cholesterol and...

